A Direct Interaction Between P53-Binding Protein 1 and Minichromosome Maintenance Complex in Hepg2 Cells

Yong Chen1,2, Chengyin Weng1, Hui Zhang2

  • 1Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Abstract

Insights

p53-binding protein 1 (53BP1) directly interacts with minichromosome maintenance (MCMs) proteins in liver cancer cells. This interaction is crucial for 53BP1

Area of Science:

  • Molecular biology
  • Cancer research
  • Hepatocellular carcinoma (HCC) studies

Background:

  • Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality globally.
  • Targeting DNA damage repair mechanisms in cancer cells presents a promising therapeutic strategy.
  • Investigating protein interactions involved in DNA repair is key to understanding cancer progression.

Purpose of the Study:

  • To explore the interaction between p53-binding protein 1 (53BP1) and minichromosome maintenance (MCMs) proteins.
  • To elucidate the role of this interaction in DNA damage response within human hepatoma HepG2 cells.

Main Methods:

  • Constructed recombinant vectors for tagged 53BP1 and MCMs, transfected into HepG2 cells.
  • Utilized immunoprecipitation (IP) and mass spectrometry (MS) to identify protein interactions.
  • Performed glutathione S-transferase (GST) pull-down assays for direct interaction validation.
  • Examined 53BP1 chromatin fraction and foci formation after MCM2/MCM6 knockdown via shRNAs under DNA damage conditions.

Main Results:

  • MCM2/3/5/6 proteins were immunoprecipitated with HA-tagged 53BP1 in HepG2 cell nuclei.
  • GST pull-down assays confirmed a direct interaction between 53BP1 and the MCMs complex.
  • Down-regulation of MCM2 or MCM6 increased non-chromatin 53BP1 levels while decreasing chromatin-bound 53BP1.
  • Knockdown of MCM2 or MCM6 significantly inhibited 53BP1 foci formation following bleomycin-induced DNA damage (P < 0.01).

Conclusions:

  • A direct interaction exists between 53BP1 and MCMs in hepatoma cells.
  • This interaction is essential for the proper chromatin localization and foci formation of 53BP1.
  • Findings contribute to understanding DNA repair mechanisms in HCC and potential therapeutic targets.

Related Concept Videos

Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.9K
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

2.1K
Protein Complex Assembly02:41

Protein Complex Assembly

Proteins can form homomeric complexes with another unit of the same protein or heteromeric complexes with different types.  Most protein complexes self-assemble spontaneously via ordered pathways, while some proteins need assembly factors that guide their proper assembly. Despite the crowded intracellular environment, proteins usually interact with their correct partners and form functional complexes.
Many viruses self-assemble into a fully functional unit using the infected host cell to...
16.8K
Protein Complex Assembly02:41

Protein Complex Assembly

2.6K
Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
607
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.1K